We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WERN:NASDAQWerner Enterprises, Inc. Analysis

Data as of 2026-08-31 - not real-time

$38.66

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Werner Enterprises, Inc. trades at $38.66, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has lost 16.5% over the past 30 days. RSI sits at 48.2, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $35.61 and resistance around $39.50.
The shares look undervalued, trading on 17.5 times earnings below a sector average of 29.1. Analyst price targets sit 11.8% above the current price. Revenue is growing at 24.0% on a -1.4% profit margin. The 1.46% dividend yield looks stretched against payout coverage.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 40.1%, a beta of 1.01 and a maximum drawdown of 28.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.

Top Market Events

Yahoo Finance1monWerner Enterprises, Inc.Werner Enterprises, Inc. WERN looks cheap from a valuation standpoint. Considering the forward 12-month price-to-sales...OMAHA, Neb., August 25, 2026--Werner Enterprises, Inc. Nasdaq: WERN , a premier transportation and logistics provider,...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 35.02
  • MACD momentum is positive
  • 30-day price change of -16.5%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 17.5 versus sector average of 29.1
  • Dividend yield of 1.46% looks stretched against payout coverage
  • Trading above the 200-day average of 35.02

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 17.5 versus sector average of 29.1
  • Dividend yield of 1.46% looks stretched against payout coverage
  • Negative profit margin of -1.4%

Key Metrics & Analysis

Financial Health

Revenue Growth24.00%
Profit Margin-1.42%
P/E Ratio17.5
ROE-3.91%
ROA0.85%
Debt/Equity68.38
P/B Ratio1.7
Op. Cash Flow$273.7M
Free Cash Flow$69.5M
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI48.2
Support$35.61
Resistance$39.50
MA 20$38.05
MA 50$40.77
MA 200$35.02
MACDBullish
VolumeDecreasing
Fear & Greed Index94.14

Valuation

Fair Value$24.27
Target Price$43.20
Upside/Downside11.76%
GradeUndervalued
TypeBlend
Dividend Yield1.46%

Risk Assessment

Beta1.01
Volatility40.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.